Cell-of-origin chromatin organization shapes the mutational landscape of cancer
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
An analysis of cell-type-specific epigenomic features reveals a relationship between epigenomic and mutational profiles; chromatin characteristics can explain a large proportion of mutational variance in cancer genomes and the mutational distribution can identify the probable cell type from which a given cancer originated from. Genomic studies have shown that different cancer types vary substantially in the local density and types of somatic mutations. This has been explained not only by differences in DNA sequence but also by other features including epigenetic organization. Shamil Sunyaev and colleague now compare mutation densities to detailed epigenetic profiles of different cell types and tissues. They demonstrate that epigenomic features of a given cell type or tissue in which a cancer arises are much stronger determinants of mutational profiles than other properties. Conversely, the findings make it possible to deduce information on the possible tissue-of-origin of a tumour based on its mutational landscape. Cancer is a disease potentiated by mutations in somatic cells. Cancer mutations are not distributed uniformly along the human genome. Instead, different human genomic regions vary by up to fivefold in the local density of cancer somatic mutations1, posing a fundamental problem for statistical methods used in cancer genomics. Epigenomic organization has been proposed as a major determinant of the cancer mutational landscape1,2,3,4,5. However, both somatic mutagenesis and epigenomic features are highly cell-type-specific6,7. We investigated the distribution of mutations in multiple independent samples of diverse cancer types and compared them to cell-type-specific epigenomic features. Here we show that chromatin accessibility and modification, together with replication timing, explain up to 86% of the variance in mutation rates along cancer genomes. The best predictors of local somatic mutation density are epigenomic features derived from the most likely cell type of origin of the corresponding malignancy. Moreover, we find that cell-of-origin chromatin features are much stronger determinants of cancer mutation profiles than chromatin features of matched cancer cell lines. Furthermore, we show that the cell type of origin of a cancer can be accurately determined based on the distribution of mutations along its genome. Thus, the DNA sequence of a cancer genome encompasses a wealth of information about the identity and epigenomic features of its cell of origin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mutation rates vary in different parts of the genome, at different stages of the life cycle and in diseases such as cancer, where they depend on the cell of origin, environmental exposure and cancer type [60][61][62] .”
From Advances in epigenetics link genetics to the environment and disease (2019) · cites this paper as [61]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Breiman, L. (2001) · Machine Learning · doi:10.1023/a:1010933404324 · Cited by 133,538
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
Integrative analysis of 111 reference human epigenomes
Roadmap Epigenomics Consortium, Kundaje, A., Meuleman, W., Ernst, J., Bilenky, M., Yen, A., Heravi-Moussavi, A., Kheradpour, P., Zhang, Z., Wang, J., et al. (2015) · Nature · doi:10.1038/nature14248 · Cited by 6,368
Self-citationMutational heterogeneity in cancer and the search for new cancer-associated genes
Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461
Self-citationThe Somatic Genomic Landscape of Glioblastoma
Brennan, C. W., Verhaak, R. G. W., McKenna, A., Campos, B., Noushmehr, H., Salama, S. R., Zheng, S., Chakravarty, D., Sanborn, J. Z., Berman, S. H., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.034 · Cited by 5,016
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
Cibulskis, K., Lawrence, M. S., Carter, S. L., Sivachenko, A., Jaffe, D., Sougnez, C., Gabriel, S., Meyerson, M., Lander, E. S., & Getz, G. (2013) · Nature Biotechnology · doi:10.1038/nbt.2514 · Cited by 4,981
Self-citationComprehensive genomic characterization of squamous cell lung cancers
The Cancer Genome Atlas Research Network (2012) · Nature · doi:10.1038/nature11404 · Cited by 3,994
Self-citationPermutation importance: a corrected feature importance measure
Altmann, A., Toloşi, L., Sander, O., & Lengauer, T. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq134 · Cited by 2,843
The accessible chromatin landscape of the human genome
Thurman, R. E., Rynes, E., Humbert, R., Vierstra, J., Maurano, M. T., Haugen, E., Sheffield, N. C., Stergachis, A. B., Wang, H., Vernot, B., et al. (2012) · Nature · doi:10.1038/nature11232 · Cited by 2,679
Self-citation
Cited by
Items 401–500 of 548
Recent advances in computational-based approaches in epigenetics studies
Joshi, A., & Romanowska, J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819414-0.00028-8 · Cited by 5
Hariprakash, J. M., Salviato, E., Mastra, F. L., Sebestyén, E., Tagliaferri, I., Silva, R. S., Lucini, F., Farina, L., Cinquanta, M., Rancati, I., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-23-1129 · Cited by 3
Ma, Y., Fang, F., Liao, K., Zhang, J., Chen, W., Liao, Y., Zhao, B., Fang, Y., Chen, Y., Wang, D., et al. (2024) · Translational Cancer Research · doi:10.21037/tcr-23-1886 · Cited by 3
“Researchers found chromatin-organized and regulated gene mutations in more than 50% of cancers (55-57).”
BackgroundImplications of noncoding regulatory functions in the development of insulinomas
Ramos-Rodríguez, M., Subirana-Granés, M., Norris, R., Sordi, V., Fernández, Á., Fuentes-Páez, G., Pérez-González, B., Balaguer, C. B., Raurell‐Vila, H., Chowdhury, M., et al. (2024) · Cell Genomics · doi:10.1016/j.xgen.2024.100604 · Cited by 3
“Our data suggest that the genome-wide aberrant deposition of H3K27ac in these tumors tends to be related to gene expression regulatory functions and shared between patients.”
Mutations in tumor signaling, metastases, and synthetic lethality establish distinct patterns
Yavuz, B. R., Sahin, U., Jang, H., Nussinov, R., & Tunçbağ, N. (2025) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1013351 · Cited by 3
“Passenger mutations were observed to be unevenly distributed across cancer genomes, appearing to stem from regional chromatin accessibility [10,11].”
Zhou, X., Ma, X., Wang, Z., Sun, C., Wang, Y., He, Y., & Zhang, H. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.10.028 · Cited by 3
Prognostic Value of Chromatin Structure Typing in Early-Stage Non-Small Cell Lung Cancer
Mao, L.-N., Wu, J.-H., Zhang, Z., Mao, L.-J., Dong, Y., He, Z., Wang, H.-Y., Chi, K., Jiang, Y.-M., & Lin, D. (2023) · Cancers · doi:10.3390/cancers15123171 · Cited by 2
“Higherorder chromatin structure regulates gene expression during cell differentiation [7], and the mutation frequency of tumor cells is also affected by chromatin organization [8,9].”
BackgroundComment l’approche génomique aide à comprendre le processus d’initiation de la réplication
Miotto, B. (2017) · médecine/sciences · doi:10.1051/medsci/20173302009 · Cited by 3
Li, X., & Thirumalai, D. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.20.050989 · Cited by 3
Evolutionary Dynamics of Non-Coding Regions in Pancreatic Ductal AdenocarcinomaPreprint
Hayashi, A., Ho, Y.-J., Makohon-Moore, A. P., Zucker, A., Hong, J., Reiter, J. G., Huang, J., Zhang, L., Attiyeh, M. A., Baez, P., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.11.294389 · Cited by 3
“…including differences in chromatin structure between enhancers (euchromatin) and intronic DNA (heterochromatin) (Schuster-Böckler and Lehner, 2012) (Polak et al., 2015), or differences in DNA repair efficiency among different regions of the genome (Janssen, Colmenares and Karpen,…”
BackgroundJiao, W., Atwal, G., Polak, P. P., Karlić, R., Cuppen, E. P. J. G., Danyi, A., de Ridder, J., van Herpen, C., Lolkema, M. P., Steeghs, N., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/214494 · Cited by 3
Self-citationSlaven, N., Lopes, R., Canale, E., Ivanoiu, D., Pacini, C., Barbosa, I. A. M., Bleu, M., Bravaccini, S., Ravaioli, S., Dieci, M. V., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.15.480537 · Cited by 3
Endometriosis lesions are oligoclonal structures derived from the normal endometriumPreprint
Ólafsson, S., Arnthorsson, A. O., Kübler, K., Sigurðsson, Á., Gunnarsdottir, H. S., Jónsson, H., Ásbjörnsdóttir, B., le Roux, L., Saemundsdottir, J., Steinthórsdóttir, V., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.25.708037 · Cited by 5
“The genomic distribution of somatic mutations along the length of each chromosome has been shown to vary with cell-type specific chromatin organization and epigenetic state ( 26 ).”
Regional mutational signature activities in cancer genomes
Timmons, C., Morris, Q., & Harrigan, C. F. (2022) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010733 · Cited by 3
Oman, M., & Ness, R. W. (2025) · Genetics · doi:10.1093/genetics/iyae215 · Cited by 2
Interplay of replication timing, DNA repair, and translesion synthesis in UV mutagenesis in yeast
Sewell, A., & Wyrick, J. J. (2025) · Nucleus · doi:10.1080/19491034.2025.2476935 · Cited by 2
“In contrast, late replicating regions in human cells tend to be heterochromatic and therefore less accessible to repair factors, which is thought to be a primary cause of elevated somatic mutation rates in late-replicating regions of the human genome [16,19,41,42].”
Bahari, F., Cohan, R. A., & Montazeri, H. (2025) · npj Precision Oncology · doi:10.1038/s41698-025-00871-3 · Cited by 3
“These fi ndings align with the previous results that the mutation rates of cancer genomes are correlated with epigenomic and chromatin organization 6,22 .”
InfluentialBeyond the Tumor Mass: From Initiating Clones to Overt Isocitrate Dehydrogenase-Mutant Gliomas
Park, J. W., Lee, J. H., & Kang, S. (2026) · DNA and Cell Biology · doi:10.1177/10445498261435336 · Cited by 2
“Increasing evidence indicates that tumorigenesis is shaped not only by genetic alterations but also by cellular context, developmental timing, epigenetic state, and microenvironmental cues (Baggiolini et al., 2021; Haigis et al., 2019; Moon et al., 2017; Polak et al., 2015).”
Phuong, D. J., Ralston, C. Q., Ezzat, T., Ashe, C. S., Armstrong, A. P., Flesken‐Nikitin, A., Yamulla, R. J., Nikitin, A. Y., & Schimenti, J. C. (2026) · Genetics · doi:10.1093/genetics/iyag098 · Cited by 2
Multi-resolution modeling of a discrete stochastic process identifies causes of cancer.
Yaari, A., Sherman, M. A., Priebe, O., Loh, P., Katz, B., Barbu, A., & Berger, B. (2021) · PubMed · Cited by 3
Chakraborty, S., Guan, Z., Begg, C. B., & Shen, R. (2024) · Biometrics · doi:10.1093/biomtc/ujae030 · Cited by 3
“It is known that somatic mutational landscape in the cancer genome is shaped by the epigenome structure of the corresponding site of origin (Polak et al. 2015).”
BackgroundMetaplastic Barrett's oesophagus represents reversion to a developmental-like epithelial cell state
Baker, S. M., Mullan, A. F., Jennings, R. E., Hanley, K. P., Ang, Y. S., Palles, C., Hanley, N. A., & Sharrocks, A. D. (2025) · Development · doi:10.1242/dev.204735 · Cited by 2
“Comparison of BO to the developing stomach as well as the distal oesophagus is important, given growing evidence implicating gastric epithelial cells as a cell of origin of BO (Polak et al., 2015; Singh et al., 2021; Nowicki-Osuch et al., 2021).”
Networks and Consortia for Epigenetic Drug Discovery
Weisenberger, D. J., & Brown, P. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802208-5.00006-0 · Cited by 3
Brettingham‐Moore, K. H., & Taberlay, P. C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802208-5.00002-3 · Cited by 4
Sarver, A. E., & Subramanian, S. (2016) · Epigenomics · doi:10.2217/epi-2016-0046 · Cited by 2
Redistribution of mutation risk in cancer
Hu, X., & De, S. (2024) · Nature Cancer · doi:10.1038/s43018-024-00728-x · Cited by 2
A mutation-level covariate model for mutational signatures
Kahane, I., Leiserson, M. D. M., & Sharan, R. (2023) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1011195 · Cited by 1
Epigenomic Sequencing Technologies
Chen, J., Keshavarzian, T., & Lupien, M. (2024) · Royal Society of Chemistry eBooks · doi:10.1039/9781837674916-00109 · Cited by 1
Abdalla, O., & Walker, C. G. (2025) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2025.104003 · Cited by 1
Structure-Guided Design of a KMT9 Inhibitor Prodrug with Cellular Activity
Wang, S., Barthes, N. P. F., Urban, S., Hazai, V., Klein, S. O., Pappert, T., Kümmel, P., Heller, N., Bacher, J., Staudt, M., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c02953 · Cited by 1
Fraternal cooperation of hierarchical cancer parallels metazoan multicellularity and eusociality
Choi, J. (2025) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.70087 · Cited by 2
“While there might be multiple cells of origin for cancer (Visvader, 2011), it is generally accepted that cancer originates from a single cell of origin endowed with stemness (Polak et al ., 2015; White & Lowry, 2015).”
Yang, P., Gao, F., Peng, S., Wei, G., Bao, G., & Yuan, L. (2025) · Thyroid Research · doi:10.1186/s13044-025-00267-2 · Cited by 1
“…[19], histone modifications [20], and noncoding RNA [21, 22], have been characterized in TC. Chromosomal accessibility is a powerful method for mapping genome-wide open chromatin patterns in multiple tumors [23, 24] and provides valuable insights into the regulatory mechanisms of TC [25].”
Jikuya, R., Johnson, T. A., Muraoka, E., Noguchi, G., Maekawa, S., Obara, W., Numakura, K., Habuchi, T., Maejima, K., Sasagawa, S., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-65303-z · Cited by 1
“Recent studies revealed that COO chromatin marks and epigenomic features, including open chromatin regions, are associated with the distribution and density of somatic mutations in the cancer genome 22 .”
InfluentialBiologically-informed regional subset analysis with CatBoost for robust tissue-of-origin prediction
Yang, S., & Kim, H. (2025) · PLoS ONE · doi:10.1371/journal.pone.0337106 · Cited by 2
The Main Cancer Theories in Focus
Paul, D. (2025) · Springer eBooks · doi:10.1007/978-3-032-08808-6_5 · Cited by 1
3D chromatin architecture in cancer: mechanisms of dysregulation and emerging therapeutic strategies
Jang, S., & Yoo, K. H. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01748-6 · Cited by 2
“This underscores a model in which the native 3D architecture imprints a non-random mutational template, effectively ‘ priming ’ the genomic landscape for speci fi c evolutionary trajectories even prior to malignant transformation 23,24 .”
Cancer Breakpoint Hotspots Versus Individual Breakpoints Prediction by Machine Learning Models
Cheloshkina, K., Bzhikhatlov, I., & Poptsova, M. S. (2020) · Lecture notes in computer science · doi:10.1007/978-3-030-57821-3_19 · Cited by 1
Investigating the tissue specificity and prognostic impact of cis-regulatory cancer risk variants
Subramanian, A., Su, S., Moding, E. J., & Binkley, M. S. (2023) · Human Genetics · doi:10.1007/s00439-023-02586-6 · Cited by 1
The Epigenetic Biomarker γH2AX: From Bench to Clinical Trials
Rogakou, E. P., Papadakis, V., & Chrousos, G. P. (2016) · Springer eBooks · doi:10.1007/978-3-319-25325-1_4 · Cited by 2
Molecular Genetics of Melanocytic Neoplasia
Hodis, E., & Garraway, L. A. (2017) · Springer eBooks · doi:10.1007/978-1-4614-7322-0_29-1 · Cited by 1
Understanding cancer breakpoint determinants with omics data
Cheloshkina, K., & Poptsova, M. S. (2020) · Integrative Cancer Science and Therapeutics · doi:10.15761/icst.1000333 · Cited by 2
“These results agree with the results for point mutation density correlation with closed chromatin state [31].”
BackgroundResultNew Techniques for Mechanical Measurements in the Superconducting Magnet Models
Guinchard, M., Artoos, K., Gerardin, A., & Kuzmin, A. (2010) · International Linear Collider · doi:10.18429/jacow-ipac2010-mopeb043 · Cited by 1
Challenges and Strategies for Utilization of Pulse Proteins
Singh, N., Kaur, P., & Katyal, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823960-5.00015-9 · Cited by 1
Molecular Genetics of Melanocytic Neoplasia
Hodis, E., & Garraway, L. A. (2019) · Springer eBooks · doi:10.1007/978-1-4614-7147-9_29 · Cited by 2
Croce, L. D., & Shilatifard, A. (2016) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2016.04.007 · Cited by 1
“Conversely, cell-of-origin chromatin organization appears to drive the spatial distribution of mutations within the genomes of different tumor types [4,5].”
Smith, T., Arndt, P. F., & Eyre‐Walker, A. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/110452 · Cited by 1
“Previous analyses have demonstrated that there is large scale variation in the rate of DNM in both the germ-line [3, 5] and the somatic tissue [8-12].”
BackgroundLi, M., Brown, A., Goncearenco, A., & Panchenko, A. R. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/354506 · Cited by 1
Clinical utility of chromatin analysis
Kleppe, A., & Danielsen, H. E. (2018) · Oncotarget · doi:10.18632/oncotarget.25991 · Cited by 1
Hou, H. (2019) · TSpace (University of Toronto) · Cited by 2
MYC amplification at diagnosis drives therapy-induced hypermutation of recurrent gliomaPreprint
Wang, J., Mu, Q., Chai, R., Liu, H., Yang, Y., Zhao, Z., Lui, M. H., Bao, Z., Song, D., Jiang, B., et al. (2021) · doi:10.21203/rs.3.rs-138020/v1 · Cited by 2
Magnani, L. (2022) · Research Square · doi:10.21203/rs.3.rs-1432636/v1 · Cited by 1
Zhang, L., Deng, T., Liufu, Z., Liu, X., Chen, B., Hu, Z., Liu, C., Tracy, M. E., Lu, X., Wen, H., et al. (2024) · eLife · doi:10.7554/elife.99340.2 · Cited by 1
Topographical archetypes of somatic mutagenesis in cancerPreprint
Lynch, A. W., Lee, S. W., Hummel, J. P., Geiger, B., Lawrence, M. S., Jin, H., Gulhan, D., & Park, P. J. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.18.719374 · Cited by 1
Self-citationMechanical Sensing of Living Systems — From Statics to Dynamics
Argoul, F., Audit, B., & Arnéodo, A. (2015) · InTech eBooks · doi:10.5772/60883
Maretty, L., Sibbesen, J. A., & Krogh, A. (2014)
Current Challenges in Cell-Type Discovery Through Single-Cell Data
Roditi, L. D. V., Macnair, W., & Claassen, M. (2015) · ITM Web of Conferences · doi:10.1051/itmconf/20150500010
“This would have the potential to identify a “cell of origin” in tumors, which has been a long-debated subject motivating many attempts to identify a cellular type capable of giving rise to invasive cancer (13, 14).”
BackgroundMining the Epigenetic Landscape
Amin, V. R., Onuchic, V., & Milosavljevic, A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800206-3.00007-0 · Cited by 1
Chromatin and Polycomb: Biology and bioinformatics
Kudrin, R., Mironov, A. A., & Stavrovskaya, E. D. (2017) · Molecular Biology · doi:10.1134/s0026893316060121
“For instance, epigenomic data available for various tissues and cell lines made it possible to demonstrate that the mutation rate in cancer cells depends on the epigenome of the cell type that has given origin to cancer [100, 101].”
BackgroundCategory Clustering: Exploring feature creation and similarity in clustering of cancer patients
Langerød, K. (2016) · NORA - Norwegian Open Research Archives
Autologous reference types can confound the detection of somatic mutation in solid cancers
Chen, X., Zou, X., Zhong, W., Peng, K., Wang, D., Fan, W., Lin, J., & Peng, J. (2018) · DNA repair · doi:10.1016/j.dnarep.2018.07.002
Meyerson, W. U., & Gerstein, M. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/450239
“Altogether, genomic sites differ in mutation rate depending on the features of those sites, the internal state of the cell [11], and environmental exposures.”
BackgroundChemotherapy resistance mechanisms and targeted therapies in leukemia
Kahn, J. D. (2019) · Utrecht University Repository (Utrecht University)
Precision oncology : oncogenic stat3 signalling in brain tumours
Tan, M. S. Y. (2019) · doi:10.32657/10220/49094
A case of small combined hepatocellular-cholangiocellular carcinoma
Osuga, T., Miyanishi, K., Tanaka, S., Nakamura, H., Sakamoto, H., Onuma, H., Murase, K., Takada, K., Kobune, M., Kato, J., et al. (2019) · Kanzo · doi:10.2957/kanzo.60.294
Pan-cancer analysis and applications
Dhawan, D. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817076-2.00015-9
Koh, L. (2019) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/138683
Chan, A. K. C. (2026) · Warwick Research Archive Portal (University of Warwick) · doi:10.82444/warw.33805207
Advances in epigenetic techniques to study development and diseases
Dzobo, K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819414-0.00032-x
Prognostic Value of the Diversity of Nuclear Chromatin Compartments in Gynaecological Carcinomas
Kleppe, A., Albregtsen, F., Trovik, J., Kristensen, G. B., & Danielsen, H. E. (2020) · Cancers · doi:10.3390/cancers12123838
“In human cancer cells, chromatin organisation has been observed to be a dominant determinant of variation in regional mutation rates [4,5].”
BackgroundOcsenas, O. (2020) · TSpace (University of Toronto)
Lineage-restricted Metabolic Identities of Mammary Epithelial Cells
Mahendralingam, M. J. (2019) · TSpace (University of Toronto)
Randomness in Cancer Breakpoint Prediction
Cheloshkina, K., Bzhikhatlov, I., & Poptsova, M. S. (2021) · Journal of Computational Biology · doi:10.1089/cmb.2020.0551
“Thus, in Polak et al. (2015), the authors could predict density of somatic point mutations with the densities of DNase hypersensitive sites, a marker of an open/close chromatin state, and densities of histone marks with a high coefficient of determination of 0.7–0.8.”
InfluentialArgentesi, G., Azizan, E. A. B. A., Zhou, J., Cabrera, C., O’Toole, S. M., Wu, X., Goodchild, E., Cottrell, E., Marker, A. J., Senanayake, R., et al. (2021) · Endocrine Abstracts · doi:10.1530/endoabs.77.oc4.2
Elisa, L. (2014) · Publications Docs-en-stock.com
Nassir, N., Bankapur, A., Samara, B., Ali, A. Y., Ahmed, A., Inuwa, I. M., Zarrei, M., Shabestari, S. A. S., Albanna, A., Howe, J., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-763046/v1
Alvarez-Buylla, E. R., Martínez‐García, J. C., Dávila-Velderrain, J., Domínguez‐Hüttinger, E., & Martínez-Sánchez, M. E. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-89354-9_3
Li, X., Sinha, S., & Thirumalai, D. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.03.482775
Chromatin organization heavily influences mutation patterns
(2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.47
Poot, R. A. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.727776019.793555748
Hannenhalli, S. S. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735088954.793558203
Faculty Opinions recommendation of Genome-wide cell-free DNA fragmentation in patients with cancer.
Pawelec, G. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735843160.793563944
Patterns of somatic mutations in normal cells
Manders, F. (2023) · Utrecht University Repository (Utrecht University) · doi:10.33540/1622 · Cited by 1
Pandey, N., Sharma, M., Mathur, A., Anene-Nzelu, C. G., Hakimullah, M., Patel, P. D., Jha, I. P., Chandra, O., Mishra, S. V., Bhattacharya, J., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.15.524115
“Several studies have been dedicated to linking properties of cancer cells and chromatin organization 1 , structural variation in their genomes 2 .”
BackgroundYuan, L., Yang, P., chen, S., Wei, G., Lu, J., Hu, X., Yang, L. C., He, X., & Bao, G. (2023) · Research Square · doi:10.21203/rs.3.rs-2584167/v1
Cell type-specific DNA replication initiation and termination in human primary cancer whole genomesPreprint
Peifer, M., Yang, T.-P., Etich, J., Acht, T., Cartolano, M., George, J., Thomas, R. K., & Fischer, M. (2023) · Research Square · doi:10.21203/rs.3.rs-3266108/v1
Predicting regional somatic mutation rates using DNA motifs
Liu, C., Wang, Z., Wang, J., Liu, C., Wang, M., Ngo, V., & Wang, W. (2023) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1011536
Magnani, L., Ivanoiu, D., Rosano, D., Slaven, N., Sofyalı, E., Barozzi, I., James, C. T., Cresswell, G. D., Corleone, G., Dhiman, H., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3443614/v1
Genome-driven cancer site characterization: An overview of the hidden genome model
Chakraborty, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-815247-8.00015-2
Assante, G., Chandrasekaran, S., Ng, S., Tourna, A., Chung, C. H., Isse, K. A., Banks, J. L., Soffientini, U., Filippi, C., Dhawan, A., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20153149
Sanjaya, P., Maljanen, K., Katainen, R., Waszak, S. M., Aaltonen, L. A., Stegle, O., Korbel, J. O., & Pitkänen, E. (2023) · Figshare · doi:10.6084/m9.figshare.23647579
Assante, G., Chandrasekaran, S., Ng, S., Tourna, A., Chung, C. H., Isse, K. A., Banks, J. L., Soffientini, U., Filippi, C., Dhawan, A., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20153146
Assante, G., Chandrasekaran, S., Ng, S., Tourna, A., Chung, C. H., Isse, K. A., Banks, J. L., Soffientini, U., Filippi, C., Dhawan, A., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20153140
Zhang, J., Liu, J. J., McGillivray, P. D., Yi, C., Lochovsky, L., Lee, D., & Gerstein, M. (2020) · Figshare · doi:10.6084/m9.figshare.13141973
Abdalla, O., & Walker, C. G. (2024) · Research Square · doi:10.21203/rs.3.rs-4342402/v1 · Cited by 1
Zhang, L., Deng, T., Liufu, Z., Liu, X., Chen, B., Hu, Z., Liu, C., Tracy, M. E., Lu, X., Wen, H., et al. (2024) · eLife · doi:10.7554/elife.99340.3
Abdalla, O., & Walker, C. G. (2024) · Research Square · doi:10.21203/rs.3.rs-4342402/v2
Zhang, L., Deng, T., Liufu, Z., Liu, X., Chen, B., Hu, Z., Liu, C., Lü, X., Wen, H., & Wu, C. (2024) · eLife · doi:10.7554/elife.99340.1 · Cited by 1
Metadata
- Authors
- Polak, P., Karlić, R., Koren, A., Thurman, R., Sandstrom, R., Lawrence, M. S., Reynolds, A., Rynes, E., Vlahoviček, K., Stamatoyannopoulos, J. A., & Sunyaev, S. R.
- Affiliations
- Broad Institute (US)
- University of Zagreb (HR)
- University of Washington (US)
- Corresponding author
- Stamatoyannopoulos, John A.
- Sunyaev, Shamil R.
- ORCID
- Venue
- Nature
- Published
- 2015-02-18
- Volume
- 518
- Issue
- 7539
- Pages
- 360-364
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4405175
- OpenAlex
- W2086239585
- Cited by
- 557
- References
- 29
- Citations by year
- 2026: 22 · 2025: 31 · 2024: 41 · 2023: 41 · 2022: 46 · 2021: 56 · 2020: 55 · 2019: 62 · 2018: 46 · 2017: 60 · 2016: 65 · 2015: 29
- FWCI
- 22.03
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-sa
- creativecommons.org/licenses/by-nc-sa/3.0/ (tdm)
- creativecommons.org/licenses/by-nc-sa/3.0/ (vor)
- Locations
- Nature (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health (HL53750)
- National Heart, Lung, and Blood Institute (P01HL053750, P01 HL53750)
- National Institute of Mental Health (R01MH101244)
- National Human Genome Research Institute (U54HG007010)
- National Cancer Institute (U54CA143874)
- National Institute of Environmental Health Sciences (U01ES017156)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Keywords
- cell of origin, chromatin accessibility, chromatin modification, DNA replication timing, somatic mutations, mutation density, tissue of origin prediction, cancer cell lines
- MeSH terms
- Chromatin, Humans, Melanocytes, Melanoma, Mutation, Neoplasms, Organ Specificity, Genome, Human, DNA Replication Timing, Epigenesis, Genetic, Cell Line, Tumor, Epigenomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.